| The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis—preliminary findings RE Banks, MJ Dunn, MA Forbes, A Stanley, D Pappin, T Naven, M Gough, ... ELECTROPHORESIS: An International Journal 20 (4‐5), 689-700, 1999 | 409 | 1999 |
| Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy KH Young, JR Baird, T Savage, B Cottam, D Friedman, S Bambina, ... PloS one 11 (6), e0157164, 2016 | 307 | 2016 |
| Timing of PD-1 blockade is critical to effective combination immunotherapy with anti-OX40 DJ Messenheimer, SM Jensen, ME Afentoulis, KW Wegmann, Z Feng, ... Clinical Cancer Research 23 (20), 6165-6177, 2017 | 304 | 2017 |
| PKC-δ is an apoptotic lamin kinase T Cross, G Griffiths, E Deacon, R Sallis, M Gough, D Watters, JM Lord Oncogene 19 (19), 2331-2337, 2000 | 282 | 2000 |
| Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors JR Baird, D Friedman, B Cottam, TW Dubensky Jr, DB Kanne, S Bambina, ... Cancer research 76 (1), 50-61, 2016 | 233 | 2016 |
| OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor MJ Gough, CE Ruby, WL Redmond, B Dhungel, A Brown, AD Weinberg Cancer research 68 (13), 5206-5215, 2008 | 192 | 2008 |
| Facets of heat shock protein 70 show immunotherapeutic potential SM Todryk, MJ Gough, AG Pockley Immunology 110 (1), 1-9, 2003 | 182 | 2003 |
| Signaling through OX40 enhances antitumor immunity SM Jensen, LD Maston, MJ Gough, CE Ruby, WL Redmond, M Crittenden, ... Seminars in oncology 37 (5), 524-532, 2010 | 173 | 2010 |
| Apoptosis or necrosis for tumor immunotherapy: what's in a name? A Melcher, M Gough, S Todryk, R Vile Journal of molecular medicine 77, 824-833, 1999 | 172 | 1999 |
| Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice MJ Gough, MR Crittenden, MC Sarff, P Pang, SK Seung, JT Vetto, HM Hu, ... Journal of immunotherapy 33 (8), 798-809, 2010 | 166 | 2010 |
| Role of the immunosuppressive microenvironment in immunotherapy GW Tormoen, MR Crittenden, MJ Gough Advances in radiation oncology 3 (4), 520-526, 2018 | 156 | 2018 |
| Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells AR Bateman, KJ Harrington, T Kottke, A Ahmed, AA Melcher, MJ Gough, ... Cancer research 62 (22), 6566-6578, 2002 | 151 | 2002 |
| Macrophages orchestrate the immune response to tumor cell death MJ Gough, AA Melcher, A Ahmed, MR Crittenden, DS Riddle, ... Cancer research 61 (19), 7240-7247, 2001 | 147 | 2001 |
| A simple method to cure established tumors by inflammatory killing of normal cells GA Daniels, L Sanchez-Perez, RM Diaz, T Kottke, J Thompson, M Lai, ... Nature biotechnology 22 (9), 1125-1132, 2004 | 144 | 2004 |
| TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking AJ Gunderson, T Yamazaki, K McCarty, N Fox, M Phillips, A Alice, T Blair, ... Nature communications 11 (1), 1749, 2020 | 129 | 2020 |
| Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? K Harrington, L Alvarez-Vallina, M Crittenden, M Gough, H Chong, ... Human gene therapy 13 (11), 1263-1280, 2002 | 119 | 2002 |
| Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy MR Crittenden, B Cottam, T Savage, C Nguyen, P Newell, MJ Gough PloS one 7 (6), e39295, 2012 | 112 | 2012 |
| A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic … T Crocenzi, B Cottam, P Newell, RF Wolf, PD Hansen, C Hammill, ... Journal for immunotherapy of cancer 4, 1-13, 2016 | 106 | 2016 |
| Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist WL Redmond, MJ Gough, B Charbonneau, TL Ratliff, AD Weinberg The Journal of Immunology 179 (11), 7244-7253, 2007 | 105 | 2007 |
| Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity MR Crittenden, L Zebertavage, G Kramer, S Bambina, D Friedman, ... Scientific reports 8 (1), 7012, 2018 | 104 | 2018 |
Pippa Newell, MDHepatobiliary and Pancreas Surgeon, The Oregon Clinic; Medical Director, Liver Cancer Program在 providence.org 的电子邮件经过验证
